Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC) Project Grant entitled “Allogeneic Stem Cell Cancer immunotherapies”.
As part of the CRC-P Program, Cartherics offers high calibre students PhD research programs of study that include international level research training, […]
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.
This is not a distant vision. It is happening right here, right now. A research team, […]
Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.
Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019
Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]
Melbourne Convention and Exhibition Centre, 25-27 March 2020
“Success Breeds Success”
The field of immunotherapy against cancers is making unprecedented progress. The Eradicate Cancer Conference “Can advanced immunotherapy make it possible?” held in March 2018 was a resounding success.
It […]
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc.
 |
 |
|
https://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php
In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs
Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]
Sydney Morning Herald (By Esther Han)
19 December 2018 — 12:00am
A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.
Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]
Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal.
I’ve always had an insatiable curiosity and a passion for big-picture ideas. Growing up both my mother and grandmother had cancer. After such an early confrontation with the absence of health — something most of us take for granted […]
Cartherics Communications Adviser Leigh Dayton reveals the lengths Cartherics co-founder and immunologist Richard Boyd will go to for a good conversation.
It was a dark and stormy night. OK, that’s a slight exaggeration, but it was the day Richard Boyd was flying from Melbourne to Sydney […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd